Publication Information
Available Issues

Journal of Viral Hepatitis


Featured in This Issue:
Genetic Variability in HCV and its Role in Antiviral Treatment Response... Performance of Noninvasive Markers for Liver Fibrosis is Reduced in HCV... Hepatitis B Virus Infection and Immunization Status - Drug Users... Monocyte Derived Dendritic Cells Retain Their Functional Capacity ...


Available Content
2008
DOTS
Genetic Variability in HCV and its Role in Antiviral Treatment Response... Performance of Noninvasive Markers for Liver Fibrosis is Reduced in HCV... Hepatitis B Virus Infection and Immunization Status - Drug Users... Monocyte Derived Dendritic Cells Retain Their Functional Capacity ...
DOTS

The Course of Hepatitis C Viraemia in Transfusion Recipients ... Switching Patients With Lamivudine Resistant Chronic HBV ... Hepatic Steatosis in Chronic Hepatitis C... Lamivudine Prevents Reactivation of Hepatitis B and Reduces Mortality ...
DOTS

Symptomatology & Health Attitudes of Chronic Hepatitis B Patients in the US... Exploring Differences in Response to Treatment in Chronic HCV... Old and Emerging Therapies in Chronic Hepatitis C: An Update... Long-Term Lamivudine Treatment of Children With Chronic Hepatitis B...
DOTS

2007
DOTS
Co-Morbid Medical & Psychiatric Illness & Substance Abuse in Veterans... Therapy Expectations & Physical Comorbidity Affect QOL in HCV... Hepatitis B Virus Polymerase Variants With Entecavir Drug Resistance... Hepatitis C Virus: From Oxygen Free Radicals to Hepatocellular Carcinoma...
DOTS

Spontaneous Clearance of Childhood Hepatitis C Virus Infection... Safety, Tolerability & Efficacy of PEG-IFN Alpha-2a & RBV - Hepatitis C... G-CSF Dosing in PEG-IFN-Alpha Induced Neutropenia... Differences of YMDD Mutational Patterns - Hepatitis B Genotypes B & C...
DOTS

In vivo Immunization in Combination With Peg-Interferon for Chronic Hep B... Early Virologic Response After Peginterferon Alpha-2a Plus Ribavirin ... Steatohepatitis is Associated with Diabetes & Fibrosis in Genotype 1b HCV... Role of Chemokines as Inflammatory Mediators in Chronic Hepatitis C ...
DOTS

Lamivudine Sensitivity & the Number of Substitutions... Risk Factors for Anaemia in HIV/Hep C Virus-Coinfected Patients... Health Professionals' Attitudes Toward Caring for People With Hepatitis C... Hepatitis C Virus Directly Associates With Insulin Resistance ...
DOTS

Serum Adiponectin in Chronic Hepatitis C and B... Cellular and Humoral Immune Response to a Hepatitis B Vaccine... The Burden of Hepatitis C in England... Long-term Follow-up of the Hepatitis C HENCORE Cohort...
DOTS

Liver Injury Associated With Enhanced T-cell Activity in Hep B Patients... Long-term Surveillance of Stem Cell Recipients With Resolved Hepatitis B... Epidemiological Characteristics and Response to Hepatitis C Treatment... Opportunities for Treating Chronic Hepatitis B and C Virus Infection ...
DOTS

Critical Role of Ribavirin for the Achievement of Early Virologic Response... High Incidence of HCV Reinfection Within Injecting Drug Users ... Clearance of Hepatitis C Virus in HIV-Infected Patients ... Therapeutic Issues in HIV/HCV-Coinfected Patients ...
DOTS

Elevated Antiviral CD4+ and CD8+ T-cell Responses in Clinical Responders... Characterization of Full-Length Hepatitis C Virus Genotype 4 Sequences... Prolonged Antiviral Therapy for HBV-Infected Health Care Workers... Transient Elastography: A New Surrogate Marker of Liver Fibrosis ...
DOTS

Impact of Inherited Prothrombotic Risk factors on Individuals - Chronic HCV... Peginterferon Alpha-2b Plus Ribavirin vs Interferon Alpha-2b Plus Ribavirin... Response Rates to Pegylated Interferon and Ribavirin in HCV/HIV Coinfection... Short-duration Therapy for Hepatitis C: Suitable For All?...
DOTS

Lower Serum Viral Loads - Young Patients With Hepatitis-B-Virus-Related HCC... Hepatitis B Treatment - Lamivudine &Tenofovir - HIV/HBV-coinfected Patients... Does the Clinical Outcome of Hepatitis C Infection Vary With the Type?... Chronic Hepatitis B Virus Infection Acquired in Childhood...
DOTS

Adefovir Dipivoxil and Pegylated Interferon-alpha-2a - Chronic Hepatitis B... Increased Expression of Vascular Endothelial Growth Factor in Small HCC... A Short Course of Pegylated Interferon-alfa in Acute HCV Hepatitis... Estimating the Future Health Burden of Chronic HCV and HIV in the US...
DOTS

Quantitative Analysis of HBV cccDNA from Clinical Specimens... In Vitro Replication Models for the Hepatitis C Virus... Impact of Hepatic Steatosis on Viral Kinetics ... Risk Factors for Hepatitis C Fibrosis: Study of Veterans With Nonveterans...
DOTS

2006
DOTS
Peginterferon Plus Ribavirin for Chronic Hepatitis C With Severe Fibrosis... Impaired Health-Related Quality of Life in Patients With CHC and Normal ALT... Assessment and Predictors of HCV Treatment in HIV/HCV Coinfection... Chronic Hepatitis B: Epidemiology and Implications for Management ... HCV-Related Advanced Fibrosis/Cirrhosis...
DOTS

Improved Outcome of Chronic HBV After Heart Transplantation ... Treatment Rates in Patients With Chronic Hepatitis C After Liver Biopsy ... Risk Factors for HCV in Patients With Unexplained Routes of Infection...
DOTS

Zidovudine Use But Not Weight-Based Ribavirin Dosing Impacts Anemia in HIV... Treatment of Hepatitis C Virus and Human Immunodeficiency Virus Coinfection... Predictive Value of Serum Globulin Levels in Chronic Hepatitis B ... Pegylated Interferon With Ribavirin in Patients With Chronic Hepatitis C ...
DOTS

Hepatitis C - Contamination of Toothbrushes: Myth or Reality?... Genotypes and Mutational Patterns of the HBV Gene ... HBV Reactivation in Patients Receiving Chemotherapy ... Antepartum Immunoprophylaxis of Hepatitis B Immunoglobulin...
DOTS

Cytotoxic CD4+ T Cells in Viral Hepatitis C... 24 Weeks vs 48 Weeks of Treatment in HCV Genotype 1... Antiviral Therapy Sensitivity May Change After Liver Transplantation in HCV... Viral Kinetics in the Treatment of Chronic Hepatitis C...
DOTS

Mutations Affecting the Replication Capacity of the Hepatitis B Virus ... Lifestyle Changes and Beliefs Regarding Disease Severity in HCV... Insulin Resistance Not Associated With Liver Fibrosis in HIV/HCV... Re-treatment of Chronic Hepatitis C Patients After Relapse...
DOTS

Overlap Lam Treatment in Patients With CHB Receiving Adefovir ... HBV-DNA Fluctuations in CHB Patients With Steroid and Lamivudine... Peginterferon and Ribavirin in Black Patients With HCV... Long-Term Effect of Interferon on HCC in HCV Cirrhosis...
DOTS

Diabetes Mellitus in Chronic Hepatitis B and C... Fibrosis Progression in Initially Mild Chronic Hepatitis C ... Hepatitis C Virus Carriers With Persistently Normal ALT Levels... Core Promoter/Precore Mutations and Viral Load in HBeAg- HBV...
DOTS

Clinical Pathways for Patients With Newly Diagnosed Hepatitis C ... Lamivudine-Resistant Mutations - Switch to Adefovir Monotherapy... Repeated High-Dose Hepatitis B Vaccine (80 mcg) - CLD Patients... Lamivudine Resistance Mutations in Chronic Hepatitis B Patients...
DOTS

A la Carte Regimen of PEG-interferon and Ribavirin in HCV... Interaction Between Hepatitis B and C Viruses in HCC...
DOTS

HBV DNA Levels as an Early Predictor of Nonresponse in CHB... Hepatitis C and Steatosis: A Reappraisal ...
DOTS

Long-term Evolution of Serum and Liver Viral Markers in HCV... Spontaneous Viral Clearance Following Acute HCV Infection...
DOTS

2005
DOTS
Nucleic Acid Testing in Cadaver Organ Donor Screening... Expression of Marker Ki-67 and p53 in HBV and HCV...
DOTS

Clinical Utility of Viral Load Measurements in Hepatitis C... Relationship of Genotypes of Hepatitis B Virus ...
DOTS

Safety and Efficacy of Peginterferon Plus Ribavirin ... Treatment of Chronic Hepatitis B...
DOTS

Lam vs Lam plus IFN Treatment for HBeAg-Negative Chronic HBV... Treatment of Hepatitis C...
DOTS

Impact of IFN on Liver Fibrosis in Patients With HBeAg- CHB ... Acute Hepatitis C Infection in HIV-Infected Patients...
DOTS

Hepatic Fibrosis Stage on Subsequent Liver Biopsy in Chronic HCV... Adefovir Against All Patterns of Lamivudine-Resistant HBV...
DOTS

2004
DOTS
Lamivudine Pulse Therapy in HBeAg-Pos Patients With Normal ALT... Prolonged High Dose of Interferon Plus Ribavirin ...
DOTS

Hepatocellular Carcinoma: Role of Hepatitis Proteins... Sustained Response After a 2-Year Course of Lamivudine in e-CHB...
DOTS

Usefulness of Liver Biopsy for Hepatitis C... Chronic Hepatitis C Patients Nonresponsive to Antiviral Therapy...
DOTS

Polymorphisms of NS5B Protein Relates to Early Clearance... Epoetin Alfa Treatment for Acute Anaemia During Interferon Plus ...
DOTS

Type I Interferon Receptor and Response to Interferon Therapy... Lamivudine Prophylaxis for Prevention of Chemotherapy-Induced... Comparison of Quality of Life, Work Productivity... Hepatitis B Virus Epidemiology, Disease Burden, Treatment,...
DOTS

Hepatitis C and Antiviral Therapy... DNA Immunization and Hepatitis C...
DOTS

2003
DOTS
Treatment With Alpha 2b Interferon and Ribavirin or Standard... Intrafamilial Spread From Patients With Sporadic Hepatitis E... Efficacy of Induction Dose of Interfon-Alpha 2b With Robavirin... Dynamics of Hepatitis C Virus Quasispecies Turnover...
DOTS

Hepatitis C: Prevalence, Predictor Variables and Prevention... Efficacy of Interferon-Alpha Daily With Ribavirin... Slow Viral Dynamics of Hepatitis C Virus Genotype 4... Apoptosis in Hepatitis C...
DOTS

Predicting Progression to Cirrhosis in Chronic Hepatitis C Virus... Peginterferon -Alpha 2a (40 kDa)... Clinical Relevance of Total HCV Core Antigen Testing... Twice-Weekly Administration of Peginterferon-alpha 2b...
DOTS

Back to Top


Related Resources
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.